A Study to Learn About the Effect of Higher Doses of Nusinersen (BIIB058) Given as Injections to Participants With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Risdiplam (ASCEND)
Clinical trial NCT05067790 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05067790
- Sponsor
- Biogen
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-21
- Primary completion
- 2027-09-24
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.